Stephen Lockhart
Pfizer (United States)(US)
Publications by Year
Research Areas
Pneumonia and Respiratory Infections, SARS-CoV-2 and COVID-19 Research, Bacterial Infections and Vaccines, Viral gastroenteritis research and epidemiology, Influenza Virus Research Studies
Most-Cited Works
- → Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine(2020)15,281 cited
- → Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates(2020)2,701 cited
- → Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults(2020)1,576 cited
- → Efficacy of a Pneumococcal Conjugate Vaccine against Acute Otitis Media(2001)1,464 cited
- → Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial(2013)1,026 cited
- → Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents(2021)921 cited
- → Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age